H2 receptor antagonists (H2RAs) in Gastrointestinal Care of Neonates and Infants: Indian Paediatricians' Perspectives Dr. Garima Soni8 Nov 2025 11:50 AM ISTGastrointestinal (GI) conditions are common in neonates and infants. These may include Gastroesophageal Reflux (GER), Gastroesophageal Reflux...
Early Dose Adjustments Help Complete 2-Year Treatment Without Losing Efficacy in High-Risk Node-Positive EBC Dr. Garima Soni5 Nov 2025 12:51 PM ISTIn the video, Dr. Carlos Barrios, director and principal investigator of the oncology research center at Hospital São Lucas, and president of the...
A Hidden Epidemic: Addressing Visceral Fat and Insulin Resistance in Non-Obese T2DM with Pioglitazone-Based Therapies Dr. K M Suryanarayana VSM5 Nov 2025 11:15 AM ISTMetabolically unhealthy non-obese individuals (MUNO) comprise around 20% of the normal-weight population and have a 3.14-fold higher risk of...
Prediabetes and Cancer Risk: The Overlooked Connection Dr. Khushboo Agarwal3 Nov 2025 11:10 AM ISTPrediabetes burden is rising globally and in India. The latest IDF 2025 Atlas estimated that in 2024, 634.8 million adults (12%) worldwide had IGT,...
Dapagliflozin and Sitagliptin FDC: Exploring Early Initiation Benefits In Young Newly Diagnosed T2D in India Dr. Rajiv Kovil1 Nov 2025 10:34 AM ISTType 2 diabetes (T2D) is a growing epidemic in India. India has 101 million people with diabetes and 136 million with prediabetes, with disease onset...
Explainer video: Assess- Evaluating Patient Readiness for Diabetes- Management Strategies Deeksha Bhandari31 Oct 2025 12:01 PM ISTDiscussing weight with people living with type 2 diabetes can be difficult, but it is vital to improving care. Many patients with overweight or...
Indian Study Finds Vildagliptin SR Effective and Safe in Type 2 Diabetes Patients Uncontrolled on Metformin: PRIME-Vilda Trial Dr. Garima Soni30 Oct 2025 12:11 PM ISTVildagliptin SR 100 mg once daily has been shown to be effective and safe in improving glycemic control in Indian T2DM patients in India not...
Advancements in Antifungal Treatment: Insights from In vitro Trials with Selenium Sulfide Dr. Kamal Kant Kohli30 Oct 2025 11:15 AM ISTFungal infections represent a significant challenge in human medicine. With increasing resistance to conventional antifungal therapies and the...
The Betami-Danblock Trial: Randomized Discontinuation Of Beta-Blockers After Myocardial Infarction Prem Aggarwal28 Oct 2025 12:30 PM ISTBETAMI-DANBLOCK evaluates whether discontinuation of beta-blockers after MI is safe in patients with preserved or mildly reduced LVEF (>40%) in the...
Reperfusion Therapy for STEMI in LMICs: A Clinical Consensus Discussion with Dr Thomas Alexander Deeksha Bhandari28 Oct 2025 12:15 PM ISTIn this video, renowned cardiologist Dr Thomas Alexander, Senior Interventional Cardiologist and Head of the Division of Cardiology at Kovai Medical...
Importance of Identifying High-Risk Node-Positive Patients in EBC Medical Dialogues Team15 Oct 2025 11:45 AM ISTIn this video a clinical case is presented of a 54-year-old postmenopausal woman with a family history of HR+/HER2- breast cancer presented with a...
EASD 2025: First-Ever Guidelines Released to Address Diabetes Distress Deeksha Bhandari14 Oct 2025 12:51 PM ISTEvery 12 minutes, a person with diabetes thinks about their condition. For many, this constant burden leads to diabetes distress-a state of...
